Zhanwang Xu

1.0k citations
44 papers · 780 indexed · h-index 13
Topics
Bone Metabolism and Diseases (11 papers)Osteoarthritis Treatment and Mechanisms (7 papers)Spine and Intervertebral Disc Pathology (5 papers)

In The Last Decade

Zhanwang Xu

40 papers receiving 772 citations

Peers

Zhanwang Xu
Comparison fields: 5 of 98
  • Molecular Biology 429
  • Rheumatology 131
  • Cancer Research 116
  • Pathology and Forensic Medicine 104
  • Oncology 104
Replace Yongjian Zhao with:
Yongjian Zhao China
Franziska Busch Germany
Chengliang Wu China
Shudong Chen China
Hongfeng Ruan China
Peijian Tong China
Shaohui Zong China
Jin Cui China
Chuangxin Lin China
Zhanwang Xu relative to Yongjian Zhao China Yongjian Zhao's profile →
Citations per field
00.5×1.5×
Yongjian Zhao · 1×
Citations per year

Countries citing papers authored by Zhanwang Xu

Since Specialization
Citations

This map shows the geographic impact of Zhanwang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanwang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanwang Xu more than expected).

Fields of papers citing papers by Zhanwang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanwang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanwang Xu. The network helps show where Zhanwang Xu may publish in the future.

Co-authorship network of co-authors of Zhanwang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanwang Xu. A scholar is included among the top collaborators of Zhanwang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanwang Xu. Zhanwang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 6
5 0
6 3
7 2
8 0
9 9
10 2
11 115
12 3
13 12
14 18
15 10
16 18
17 75
18 3
19 31
20
XLINICAL STUDY ON COMPATIBILITY OF RABBIT MARROW STROMA CELLS AND BIOLOGICAL ACTIVITY GLASS FRAME
1

About Zhanwang Xu

Zhanwang Xu is a scholar working on Rheumatology, Cancer Research and Orthopedics and Sports Medicine, having authored 44 papers that have together received 780 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (11 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Spine and Intervertebral Disc Pathology (5 papers). The work is most often cited by research in Orthopedics and Sports Medicine (80 citations), Rheumatology (131 citations) and Cancer Research (116 citations). Zhanwang Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Nianhu Li, Zhichao Li, Shang‐You Yang, Paul H. Wooley, Dandan Li, Shigui Yan, Weiqi Yan, Kerong Dai, Wenxiang Cheng and Peng Zhang. Their work appears in journals such as Experimental Cell Research, European Journal of Pharmacology and Pharmacological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026